Home
Home

Xtandi

Biotech Stock Roundup: Strong Show from Biogen & Alexion; Medivation PREVAILs

Biotech Stock Roundup: Strong Show from Biogen & Alexion; Medivation PREVAILs
Yahoo/Zacks.com

This Week in Biotech: Let's Get Clinical!

This Week in Biotech: Let's Get Clinical!
Motley Fool

Medivation Inc. and Astellas Up the Ante against Johnson & Johnson

Medivation Inc. and Astellas Up the Ante against Johnson & Johnson
Motley Fool

Medivation prostate cancer drug impresses in pre-chemo study

Medivation prostate cancer drug impresses in pre-chemo study
Yahoo/Reuters

Slowing Sales for Johnson & Johnson's Zytiga May Be Good News for Medivation

Slowing Sales for Johnson & Johnson's Zytiga May Be Good News for Medivation
Motley Fool

Johnson & Johnson And Medivation: A Prostate Cancer Marketshare

Johnson & Johnson And Medivation: A Prostate Cancer Marketshare
Seeking Alpha

Johnson & Johnson Vs. Medivation In Prostate Cancer Race

Johnson & Johnson Vs. Medivation In Prostate Cancer Race
Seeking Alpha

Here's Why Medivation Jumped Higher This Week

Here's Why Medivation Jumped Higher This Week
Motley Fool

Can Xtandi Become the Go-To Prostate Drug?

Can Xtandi Become the Go-To Prostate Drug?
Motley Fool

Dendreon: Crushed By JNJ/Medivation Or By Own Management?

Dendreon: Crushed By JNJ/Medivation Or By Own Management?
Seeking Alpha